» Articles » PMID: 15040818

The Tissue Microarray Data Exchange Specification: Implementation by the Cooperative Prostate Cancer Tissue Resource

Overview
Publisher Biomed Central
Specialty Biology
Date 2004 Mar 26
PMID 15040818
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Tissue Microarrays (TMAs) have emerged as a powerful tool for examining the distribution of marker molecules in hundreds of different tissues displayed on a single slide. TMAs have been used successfully to validate candidate molecules discovered in gene array experiments. Like gene expression studies, TMA experiments are data intensive, requiring substantial information to interpret, replicate or validate. Recently, an open access Tissue Microarray Data Exchange Specification has been released that allows TMA data to be organized in a self-describing XML document annotated with well-defined common data elements. While this specification provides sufficient information for the reproduction of the experiment by outside research groups, its initial description did not contain instructions or examples of actual implementations, and no implementation studies have been published. The purpose of this paper is to demonstrate how the TMA Data Exchange Specification is implemented in a prostate cancer TMA.

Results: The Cooperative Prostate Cancer Tissue Resource (CPCTR) is funded by the National Cancer Institute to provide researchers with samples of prostate cancer annotated with demographic and clinical data. The CPCTR now offers prostate cancer TMAs and has implemented a TMA database conforming to the new open access Tissue Microarray Data Exchange Specification. The bulk of the TMA database consists of clinical and demographic data elements for 299 patient samples. These data elements were extracted from an Excel database using a transformative Perl script. The Perl script and the TMA database are open access documents distributed with this manuscript.

Conclusions: TMA databases conforming to the Tissue Microarray Data Exchange Specification can be merged with other TMA files, expanded through the addition of data elements, or linked to data contained in external biological databases. This article describes an open access implementation of the TMA Data Exchange Specification and provides detailed guidance to researchers who wish to use the Specification.

Citing Articles

REDCap and the National Mesothelioma Virtual Bank-a scalable and sustainable model for rare disease biorepositories.

Rashid R, Copelli S, Silverstein J, Becich M J Am Med Inform Assoc. 2023; 30(10):1634-1644.

PMID: 37487555 PMC: 10531116. DOI: 10.1093/jamia/ocad132.


Inhibition of Scavenger Receptor Class B Type 1 (SR-B1) Expression and Activity as a Potential Novel Target to Disrupt Cholesterol Availability in Castration-Resistant Prostate Cancer.

Pandey M, Cuddihy G, Gordon J, Cox M, Wasan K Pharmaceutics. 2021; 13(9).

PMID: 34575583 PMC: 8467449. DOI: 10.3390/pharmaceutics13091509.


PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer.

Wozniak D, Kajdacsy-Balla A, Macias V, Ball-Kell S, Zenner M, Bie W Nat Commun. 2017; 8(1):1508.

PMID: 29142193 PMC: 5688148. DOI: 10.1038/s41467-017-01574-5.


microRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma.

Dambal S, Giangreco A, Acosta A, Fairchild A, Richards Z, Deaton R J Steroid Biochem Mol Biol. 2017; 167:192-202.

PMID: 28089917 PMC: 5304339. DOI: 10.1016/j.jsbmb.2017.01.004.


Prediction of prostate cancer recurrence using quantitative phase imaging.

Sridharan S, Macias V, Tangella K, Kajdacsy-Balla A, Popescu G Sci Rep. 2015; 5:9976.

PMID: 25975368 PMC: 4432311. DOI: 10.1038/srep09976.


References
1.
Berman J, Edgerton M, Friedman B . The tissue microarray data exchange specification: a community-based, open source tool for sharing tissue microarray data. BMC Med Inform Decis Mak. 2003; 3:5. PMC: 165444. DOI: 10.1186/1472-6947-3-5. View

2.
Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S . Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998; 4(7):844-7. DOI: 10.1038/nm0798-844. View

3.
Solbrig H . Metadata and the reintegration of clinical information: ISO 11179. MD Comput. 2000; 17(3):25-8. View

4.
Perrone E, Theoharis C, Mucci N, Hayasaka S, Taylor J, Cooney K . Tissue microarray assessment of prostate cancer tumor proliferation in African- American and white men. J Natl Cancer Inst. 2000; 92(11):937-9. DOI: 10.1093/jnci/92.11.937. View

5.
Halvorsen O, Haukaas S, Akslen L . Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer. Clin Cancer Res. 2003; 9(4):1474-9. View